FDA Approves Qiagen’s IVD Products
Molecular diagnostics solutions provider, Qiagen (NASDAQ:QGEN) recently received 510(k) clearances from the US Food and Drug Administration (FDA) for two of its products for in vitro diagnostic use (IVD) in the US. Of the two products, Rotor-Gene Q MDx provides a real-time polymerase chain reaction (PCR) testing in molecular IVD applications while the artus Infl A/B [...]
Molecular diagnostics solutions provider, Qiagen (NASDAQ:QGEN) recently received 510(k) clearances from the US Food and Drug Administration (FDA) for two of its products for in vitro diagnostic use (IVD) in the US. Of the two products, Rotor-Gene Q MDx provides a real-time polymerase chain reaction (PCR) testing in molecular IVD applications while the artus Infl A/B RG RT-PCR Kit is a compatible test on Rotor-Gene platform to detect Influenza A/B.
Qiagen is currently witnessing higher demand … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards